Update: June 5th, 2025 Author: Eric Patterson, LPC (No change) Medical Reviewer: Benjamin Troy, MD (No change) Primary Changes: Edited for clarity and accuracy
Find articles by Dreyfuss, J
Currently licensed standard-dose diabetes tablets in the UK generally yield lower average weight loss results than dedicated weight loss injections
Frequently Asked Questions What is Retatrutide used for in research
Semaglutide (Ozempic, Wegovy) has a half-life of approximately 7 days, requiring approximately 5 weeks for 97% clearance from the body after the final injection
The aggressive titration tail in the 12 mg arm of the Phase 2 trial was strongly associated with higher rates of transient gastrointestinal adverse events, which is why researchers generally favor slower escalation when tolerability is prioritized